Top compounds associated with response to CTD-2545G14.7


Feature Type Standardized
Nominal ANOVA
mRNA MK 1775 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA SNS-032 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA decitabine CTRPv2 pan-cancer AAC -0.022 0.4
mRNA ML006 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.029 0.4
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.028 0.4
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA UNC0638 CTRPv2 pan-cancer AAC 0.029 0.4
mRNA BRD-K28456706 CTRPv2 pan-cancer AAC 0.029 0.4
Download CSV